Integer Holdings Corporation (ITGR)

US — Healthcare Sector
Peers: GKOS  KIDS  CNMD  LIVN  VREX  AVNS 

Automate Your Wheel Strategy on ITGR

With Tiblio's Option Bot, you can configure your own wheel strategy including ITGR - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol ITGR
  • Rev/Share 51.2288
  • Book/Share 48.6239
  • PB 2.2067
  • Debt/Equity 0.7755
  • CurrentRatio 3.4136
  • ROIC 0.0515

 

  • MktCap 3759234040.0
  • FreeCF/Share 4.6957
  • PFCF 22.8505
  • PE 45.4763
  • Debt/Assets 0.3919
  • DivYield 0
  • ROE 0.0505

 

  • Rating B
  • Score 3
  • Recommendation Neutral
  • P/E Score 1
  • DCF Score 4
  • P/B Score 3
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Upgrade ITGR Citigroup Neutral Buy -- $140 May 22, 2025
Initiation ITGR Raymond James -- Outperform -- $145 March 28, 2025
Downgrade ITGR Oppenheimer Outperform Perform -- -- Feb. 21, 2025
Resumed ITGR Wells Fargo -- Overweight -- $160 Dec. 3, 2024

News

Integer Holdings Corporation (ITGR) Q4 2024 Earnings Call Transcript
ITGR
Published: February 20, 2025 by: Seeking Alpha
Sentiment: Neutral

Integer Holdings Corporation (NYSE:ITGR ) Q4 2024 Earnings Conference Call February 20, 2025 9:00 AM ET Company Participants Andrew Senn – Senior Vice President-Strategy, Business Development and Investor Relations Joe Dziedzic – President and Chief Executive Officer Diron Smith – Executive Vice President and Chief Financial Officer Conference Call Participants Brett Fishbin – KeyBanc Capital Markets Craig Bijou – Bank of America Matthew O'Brien – Piper Sandler Richard Newitter – Truist Securities Nathan Treybeck – Wells Fargo Suraj Kalia – Oppenheimer Operator Hello and welcome to the Integer Holdings Corporation Fourth Quarter 2024 Earnings Call. All lines have been placed …

Read More
image for news Integer Holdings Corporation (ITGR) Q4 2024 Earnings Call Transcript
Integer Holdings Corporation Reports Results for Fourth Quarter and Full Year 2024
ITGR
Published: February 20, 2025 by: GlobeNewsWire
Sentiment: Neutral

~ Strong 4Q and Full Year sales and profit increase versus last year ~ ~ Expect 8% to 10% sales growth in 2025 with expanding margins ~ PLANO, Texas, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading contract development and manufacturing organization, today announced results for the three and twelve months ended December 31, 2024. Unless otherwise stated, all results and comparisons are from continuing operations.

Read More
image for news Integer Holdings Corporation Reports Results for Fourth Quarter and Full Year 2024
Integer to Present at Raymond James & Associates' 46th Annual Institutional Investor Conference and KeyBanc Capital Markets Healthcare Forum
ITGR
Published: February 18, 2025 by: GlobeNewsWire
Sentiment: Neutral

PLANO, Texas, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contract development and manufacturing organization (CDMO), today announced participation at the following upcoming investor conferences. Integer will participate at the 2025 Raymond James & Associates' 46th Annual Institutional Investor Conference, to be held March 3-5, 2025, in Orlando, Florida.

Read More
image for news Integer to Present at Raymond James & Associates' 46th Annual Institutional Investor Conference and KeyBanc Capital Markets Healthcare Forum

About Integer Holdings Corporation (ITGR)

  • IPO Date 2000-09-29
  • Website https://www.integer.net
  • Industry Medical - Devices
  • CEO Joseph W. Dziedzic
  • Employees 11000

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through Medical and Non-Medical segments. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.